Allergic disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or female, and sign the informed consent form before conducting any research operation; 2. Aged over 18; 3. Patients diagnosed with allergic rhinitis or allergic asthma; 4. Indications for specific immunotherapy in accordance with the 2012 Chinese clinical practice expert consensus on specific immunotherapy.
Exclusion criteria
Exclusion criteria: 1. The subject is in the acute exacerbation or active phase of any disease and other unstable clinical conditions; Including but not limited to myocardial infarction, stroke, and shock in recent 3 months; In the last 4 weeks, the function of gravity center was unstable, angina pectoris, massive hemoptysis, and seizures; Pneumothorax, giant pulmonary bulla and not prepared for surgical treatment; Perforation of the tympanic membrane; After closed drainage of pneumothorax or empyema; Uncontrolled hypertension (systolic blood pressure>200 mmHg, diastolic blood pressure>100 mmHg); Heart rate>120 times/minute; 2. Patients who cannot complete the questionnaire evaluation (including those who cannot read, express their opinions through alternative means, and understand the questions in the questionnaire, etc.); 3. Has been diagnosed as an aortic aneurysm; 4. Pregnant women; 5. Conforms to the contraindications of specific immunotherapy in the 2012 Chinese clinical practice expert consensus.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Asthma symptoms;Rhinitis symptoms; | — |
Countries
China
Contacts
Chongqing Northern Kuanren Hospital